glp-1 news insurers What Is Insurance Prior Authorization for GLP-1s? Health insurer Cigna will stop

Potential Benefits of GLP-1 RAs Known for their metabolic benefits, emerging studies suggest GLP-1 RAs may help improve kidney function, cardiovascular health, non-alcoholic fatty liver disease, Alzheimer's disease and Parkinsons disease

This is also why random or sporadic injections often fail to produce strong results

Liver histology Liver samples were fixed in 4% paraformaldehyde for 24 h, rapidly frozen, and embedded in OCT compound

Christine CW, Bankiewicz KS, Van Laar AD, et al

Study period 1/1/2017 to 7/1/2025 Study population: inclusion Patients with A GLP-1 prescription for at least 90 days At least five pounds of weight loss while on the GLP-1 A weight reading between 30 days prior through 3 days after starting the GLP-1 A weight reading within 30 days of stopping the GLP-1 At least one weight reading 1 to 24 months following end of the GLP-1 Study population: exclusion Thyroid conditions (ever): ICD-10-CM E03*or E05* Eating disorders (ever): ICD-10-CM F50* Pregnancy within a year before GLP-1 start through GLP-1 stop Censoring Other weight loss medication or restart of GLP-1 Amputation Bariatric surgery Pregnancy that started in period after GLP-1 was stopped Outcomes Percent of weight change relative to initial weight loss after end of GLP-1 treatment GLP-1 A medication with a simple generic of semaglutide, liraglutide, or tirzepatide

Research Report, IQVIA, Jan 18, 2023